These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 5616299)

  • 21. The histoid leproma. Its characteristics and significance.
    Rodriguez JN
    Int J Lepr Other Mycobact Dis; 1969; 37(1):1-21. PubMed ID: 5817631
    [No Abstract]   [Full Text] [Related]  

  • 22. [State of the endometrium in leprosy].
    Vishnevskaia LG; Bogush TG
    Akush Ginekol (Mosk); 1968 Aug; 44(8):64-8. PubMed ID: 5760937
    [No Abstract]   [Full Text] [Related]  

  • 23. Studies on sulfone resistance in leprosy. 2. Treatment with a riminophenazine derivative (B.663).
    Pettit JH; Rees RJ
    Int J Lepr Other Mycobact Dis; 1966; 34(4):391-7. PubMed ID: 6006070
    [No Abstract]   [Full Text] [Related]  

  • 24. Length of continued treatment of an inactive case of leprosy.
    Dharmendra
    Lepr India; 1976 Jul; 48(3):212-6. PubMed ID: 1022967
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of sulphone resistant leprosy--a review of sixty one cases.
    Seshadri PS; Ravi NT
    Lepr India; 1982 Oct; 54(4):639-47. PubMed ID: 6191123
    [No Abstract]   [Full Text] [Related]  

  • 26. The promin treatment of leprosy. A progress report.
    Faget GH; Pogge RC; Johansen FA; Dinan JF; Prejean BM; Eccles CG
    Int J Lepr Other Mycobact Dis; 1966; 34(3):298-310. PubMed ID: 5950351
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment of leprosy by sulfones and delayed action sulfonamides. Comparison of therapeutic results in 100 cases].
    Faye I; Privat Y; Bellossi A
    Bull Soc Med Afr Noire Lang Fr; 1968; 13(1):119-24. PubMed ID: 5713742
    [No Abstract]   [Full Text] [Related]  

  • 28. [Lights and shadows in the treatment of leprosy].
    Bertaccini G
    G Ital Dermatol Minerva Dermatol; 1966; 107(5):437-46. PubMed ID: 4869129
    [No Abstract]   [Full Text] [Related]  

  • 29. [Long-term observations on the topical administration of promin in ocular leprosy].
    Bouzas A
    Arch Ophtalmol Rev Gen Ophtalmol; 1971; 31(8):629-36. PubMed ID: 4256932
    [No Abstract]   [Full Text] [Related]  

  • 30. 4:4 diacetyl-diamino-diphenyl sulphone in the treatment of leprosy.
    Kundu S; Ghosh S
    Bull Calcutta Sch Trop Med; 1972 Apr; 20(2):30-1. PubMed ID: 4666676
    [No Abstract]   [Full Text] [Related]  

  • 31. [Results of modern therapy of leprosy].
    Schuppli R
    Hautarzt; 1969 Mar; 20(3):116-8. PubMed ID: 5355958
    [No Abstract]   [Full Text] [Related]  

  • 32. [The main anti-leprosy drugs, their respective costs and refunding by Social Security].
    Merklen FP
    Bull Acad Natl Med; 1968 Apr; 152(13):220-2. PubMed ID: 4913494
    [No Abstract]   [Full Text] [Related]  

  • 33. Biological therapy of leprosy.
    Cochrane RG
    Dermatol Int; 1967; 6(4):243-6. PubMed ID: 5599066
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparative tests of glucosulfone sodium (promin), thiocarlid (lsoxyl), and two INH-derivatives with Stefansky-leprosy of the white rat.
    Meyer-Rohn J
    Int J Lepr Other Mycobact Dis; 1971; 39(2):354-7. PubMed ID: 5169804
    [No Abstract]   [Full Text] [Related]  

  • 35. [Findings of the real value of sulphonotherapy in the programs of prevention of leprosy].
    Lima Lde S
    Rev Bras Leprol; 1968-1969; 36(1):31-6. PubMed ID: 5748409
    [No Abstract]   [Full Text] [Related]  

  • 36. Pathology--the doorway to the understanding of leprosy. Ward Burdick Award Address.
    Binford CH
    Am J Clin Pathol; 1969 Jun; 51(6):681-98. PubMed ID: 4890371
    [No Abstract]   [Full Text] [Related]  

  • 37. Tuberculoid leprosy or sarcoidosis? A diagnostic dilemma.
    Ramanujam K
    Lepr India; 1982 Apr; 54(2):318-23. PubMed ID: 7132299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanism of action of sulfones.
    Bergel M
    Int J Lepr Other Mycobact Dis; 1981 Mar; 49(1):89-90. PubMed ID: 7195883
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunotherapy of lepromin-negative borderline leprosy patients with low-dose Convit vaccine as an adjunct to multidrug therapy; a six-year follow-up study in Calcutta.
    Chaudhury S; Hajra SK; Mukerjee A; Saha B; Majumdar V; Chattapadhya D; Saha K
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):56-62. PubMed ID: 9207754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequency and extent of thickening of the nucleated epidermis in leprosy lesions.
    Rea TH
    Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):410-6. PubMed ID: 11332284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.